7 July 1988
COMMERCIAL ITEM DESCRIPTION
POTASSIUM CHLORIDE, L-LYSINE MONOHYDROCHLORIDE,
AND POTASSIUM BICARBONATE TABLETS, EFFERVESCENT
The General Services Administration has authorized the use of this Commercial Item Description.
Shall be a flavored, effervescent tablet containing 1.125 grams of Potassium Chloride, 0.5 grams of Potassium Bicarbonate, USP, and 0.913 grams of L-Lysine Monohydrochloride, equivalent to 20 mEq of Potassium and 20 mEq of Chloride.
Shall contain citric acid, saccharin, flavoring, coloring and other suitable ingredients to make and effervescent tablet.
Shall be in accordance with the requirements of the FDA.
Shall assay to contain not less than 18.6 mEq and not more than 21.4 mEq of Potassium, not less than 18.6 mEq and not more than 21.4 mEq of Chloride, and not less than 849 mg and not more than 977 mg of L-Lysine Monohydrochloride when determined by a suitable, accurate and reproducible method(s).
Shall have a hardness range of 1.5 to 5 Kg when 20 tablets are tested using a Stokes hardness tester or other comparable tester. As an alternate, shall have a hardness of not less than 5 kiliponds (kp) using the Schleuniger Tester.
Shall dissolve without agitation in not more than 6 minutes when 20 tablets are individually dissolved in 90 ml of water at 15° ± 2°C. In addition, shall efferverse during dissolution. During the shelf life of the tablet, it shall dissolve in not more than 7 minutes.
DISTRIBUTION STATEMENT A. Approved for public release; distribution is unlimited.
For Parts Inquires submit RFQ to Parts Hangar, Inc.
© Copyright 2015 Integrated Publishing, Inc.
A Service Disabled Veteran Owned Small Business